Global Parkinson’s Disease Drugs Market to Reach $8.1 Billion by 2027 Amid the COVID-19 crisis, the global market…
Category: Insights
Worldwide Nephrology Devices Industry to 2025 – Rising Awareness about the Benefits of Nephrological Devices Presents Opportunities
The “Global Nephrology Devices Market (2020-2025) by Device Type, End User And Geography, Impact of Covid-19, Ansoff…
NeuroBo Pharmaceuticals to Participate in H.C. Wainwright Global Life Sciences Conference
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that Company management will participate in the…
Cedar Partners With Hartford HealthCare to Prioritize the Patient Financial Experience
Hartford HealthCare, Connecticut’s most comprehensive healthcare system, and Cedar, an innovative patient engagement and financial technology platform, today…
Worldwide Spectacle Industry to 2026 – Players Include EssilorLuxottica, Novartis and Carl Zeiss Among Others
The “Global Spectacle Market By Parts (Lens and Frames), By Distribution Channel (Online and Offline), By Region,…
Integrated Care Physicians Appoint Veteran HCA Healthcare Executive Heather Rohan as Executive Chairman
Integrated Care Physicians, Inc. (“ICP” or the “Company”), a provider of emergency room staffing and management…
eHealth, Inc. to Present at Barclays Global Healthcare Conference
eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance marketplace, today announced that its management will present…
Physician Growth Partners Advises Kellis Eye & Laser Center on Partnership With Ridgemont-Backed Sunvera Group
Physician Growth Partners (“PGP”) is pleased to announce a partnership between Kellis Eye & Laser Center (“KELC”) and…
Alternative meat startup Next Meats Co., Ltd and microalgae biotech company euglena Co., launch “NEXT Euglena Yakiniku EX” containing microalgae
Next Meats Co., LTD, the controlling shareholder of Next Meats Holdings, Inc. (“OTC: NXMH”) announced that they had…
Tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes in two phase 3 trials from Lilly’s SURPASS program
Tirzepatide led to significant A1C and body weight reductions from baseline in adults with type 2…